PASADENA, Calif. - ExchangeRight's sister company, Telos Capital, a private equity company that focuses on discounted and opportunistic value-add real estate investments across all asset classes and sectors, has brought its TCF18 Norwood, MA Biotech Facility, LLC investment full cycle on behalf of its investors. In just over a year, the investment generated total returns of approximately 142-143% of originally invested equity and a net investor annual internal rate of returns of approximately 38% annualized, three times higher than its original base-case projected rate of return.
TCF18 Norwood, MA Biotech Facility, LLC was invested in an office building with research and development space that was redeveloped and net-leased on a 15-year term to Moderna, a public biotech company with one of the largest IPOs in biotech history. Moderna has continued to remain in the national news as one of the leaders in the race to produce a vaccine for the COVID-19 virus.
“Moderna’s commitment to the building through tenant improvements, and the fact that Moderna is a frontrunner in the race for a COVID-19 vaccine as the first company in the United States to conduct a Phase 3 clinical trial of a vaccine, brought a significant amount of value to the property and our investment,” said Joshua Ungerecht, a managing partner of Telos and ExchangeRight. “We are very pleased with the outcome that we were able to achieve on behalf of investors, representatives, and advisors who entrust us with their wealth.”
About Telos Capital
Telos Capital targets deeply discounted, value-add, or opportunistic private real estate investments across all asset classes and sectors. The principals of Telos invest side-by-side with investors and are generally the largest investors in the company’s projects. Telos is affiliated with ExchangeRight Real Estate, one of the nation’s largest 1031 DST sponsors. Together their total assets under management are over $2.8 billion and are diversified across more than 700 properties of over 14 million square feet located throughout 38 different states. More than 3,500 investors have trusted the principals of Telos and ExchangeRight with the stewardship of their wealth and income. For more information, visit www.teloscapitalfunds.com.
ExchangeRight is a vertically integrated real estate investment firm with over $2.8 billion in assets under management together with its affiliates. ExchangeRight pursues its mission to empower people to be secure, free, and generous by providing income funds and 1031-exchangeable investment offerings that target secure capital, stable income, and strategic exits. The company strategically acquires and manages long-term, net-leased assets backed by investment-grade corporations that operate essential businesses successfully in the necessity-based retail and healthcare industries. For more information, visit www.exchangeright.com.